[In vitro sensitivity test of a cultured human ovarian cancer cell line to anticancer agents]. 1985

S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya

In vitro tests were performed to assess the sensitivity to six anticancer agents-ACT-D, ADM, CDDP, CQ, 5-FU and MMC-of a JOHYL-1 (ascites type) cell line from human dysgerminoma which was used as challenge strain. For comparative assessment, anticancer sensitivity was expressed as the ratio of IC50 and IC90 to LD50 (i.v.) in mice. Drug dose-response and time-response curves were plotted, and the IC50 ratio was calculated, for each test compound in order to investigate the mechanism of anticancer action. The results obtained were as follows. CQ proved to be remarkably active and ADM fairly active against JOHYL-1 (ascites), but 5-FU, CDDP and MMC varied remarkably with the parameter of measurement employed. Analysis of IC50 ratio data and patterns of cell growth inhibition indicated the growth-inhibitory effect of CDDP to be concentration-and time-dependent. The results of the present study are in close accord with the pattern of action reported in the literature.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002225 Carbazilquinone An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. Carboquinone,Carboquone,Esquinon
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum

Related Publications

S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
April 1992, Nihon Sanka Fujinka Gakkai zasshi,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
July 1995, Annals of oncology : official journal of the European Society for Medical Oncology,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
January 1983, Cancer chemotherapy and pharmacology,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
August 1981, British journal of cancer,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
October 1982, Gynecologic oncology,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
March 1982, Nihon Sanka Fujinka Gakkai zasshi,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
September 1988, Zhonghua fu chan ke za zhi,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
January 2014, Oncology reports,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
March 1987, Asia-Oceania journal of obstetrics and gynaecology,
S Fujiya, and M Yasuda, and K Tahira, and Y Nakabayashi, and M Yoshioka, and Y Terashima, and S Hatiya
October 1989, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!